Go Back
QurAlis
We now have an unprecedented deep understanding of the disease and the disease mechanisms which creates an opportunity to realize real treatment breakthroughs.
More Details
Recent major scientific discoveries, such as disease-causing genetic alterations or the link between STATHMIN-2 and TDP-43 (discovered by our co-founder Kevin Eggan), show that different disease drivers cause the development of ALS. Like cancer, these disease mechanisms need to be treated with precision therapies.
QurAlis was founded by an internationally recognized team of neurodegenerative biologists from Harvard Medical School and Harvard University to leverage these emerging insights and new technologies.